Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care
Summary: Background: The vast majority of individuals with familial hypercholesterolaemia in the general population remain unidentified worldwide. Recognising patients most likely to have the condition, to enable targeted specialist assessment and treatment, could prevent major coronary morbidity an...
Saved in:
Main Authors: | Stephen Weng, PhD (Author), Joe Kai, ProfMD (Author), Ralph Akyea, MPH (Author), Nadeem Qureshi, ProfDM (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK
by: Barbara Iyen, et al.
Published: (2021) -
Inclisiran for the treatment of hypercholesterolaemia
by: Joel C Marrs, et al.
Published: (2024) -
Obesity and long‐term outcomes after incident stroke: a prospective population‐based cohort study
by: Ralph K. Akyea, et al.
Published: (2021) -
Familial Hypercholesterolaemia: An Updated Overall Management
by: Mohd Kasim, Noor Alicezah, et al.
Published: (2020) -
Koebner Phenomenon In Type II Hypercholesterolaemia
by: Hemanthkumar, et al.
Published: (1999)